Pyrinas, aims to offer investors the opportunities to investing in different property types in major markets across the globe.
The fund aims at value-added investment opportunities in key locations including Greater Boston, San Francisco and Houston in the U.S. and Toronto in Canada with capability for conversion to life sciences laboratory space and en-bloc renovation projects. It tries to provide tenants with plug-and-play office, laboratory and co-working space; support resources; shared equipment and services; creative amenities; and strategic programming to enhance their growth trajectories / to satisfy key unmet needs for turn-key office / laboratory space. The fund targets to deliver returns with Net IRR of 15%-19% p.a. (leveraged after fund fees, expenses, and fund tax but before individual investors’ taxes) through its value-added investments in the healthcare and medical real estate in North America.